相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study
Eduardo Martinez de Duenas et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The AURORA initiative for metastatic breast cancer
D. Zardavas et al.
BRITISH JOURNAL OF CANCER (2014)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
HER2 aberrations in cancer: Implications for therapy
Min Yan et al.
CANCER TREATMENT REVIEWS (2014)
Anticancer drug development: moving away from the old habits
Felipe Ades et al.
CURRENT OPINION IN ONCOLOGY (2014)
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
Felipe Ades et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
Fabrice Andre et al.
LANCET ONCOLOGY (2014)
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olof Bjarnadottir et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
I-SPY 2 may change how clinical trials are conducted
Carrie Printz
CANCER (2013)
Personalized therapy for breast cancer: a dream or a reality?
Dimitrios Zardavas et al.
FUTURE ONCOLOGY (2013)
Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research
Naihua Duan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Designing Transformative Clinical Trials in the Cancer Genome Era
Stefan Sleijfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Emerging targeted agents in metastatic breast cancer
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
Leticia De Mattos-Arruda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis
Elsa Curtit et al.
ONCOLOGIST (2013)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Molecular prescreening to select patient population in early clinical trials
Jordi Rodon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor
Robyn Macfarlane et al.
ONCOLOGIST (2012)
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Ryan B. Corcoran et al.
CANCER DISCOVERY (2012)
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
Renata Duchnowska et al.
BREAST CANCER RESEARCH (2012)
Should liver metastases of breast cancer be biopsied to improve treatment choice?
G. Curigliano et al.
ANNALS OF ONCOLOGY (2011)
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
Ulla Wilking et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
Sirwan Hadad et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
Jeanette Dupont Jensen et al.
CLINICAL CANCER RESEARCH (2011)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve et al.
MODERN PATHOLOGY (2011)
PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
Ana M. Gonzalez-Angulo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
N of 1, two contemporary arm, randomised controlled clinical trial for bilateral epicondylitis: a new study design
Luigia Scudeller et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
C. Simmons et al.
ANNALS OF ONCOLOGY (2009)
A Comparison of Phase II Study Strategies
Sally Hunsberger et al.
CLINICAL CANCER RESEARCH (2009)
N-of-1 Double-Blind, Randomized Controlled Trial of Tramadol to Treat Chronic Cough
Priscila Gebrim Louly et al.
CLINICAL THERAPEUTICS (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
